STAT3 and hepatocellular carcinoma: After confirming that nanomedicines have a high targeting distribution function and that the miR‐125b‐5p/STAT3 axis has a regulatory effect in vitro, we introduced a subcutaneous transplantation HCC model to investigate whether nanomedicines could achieve a therapeutic effect in vivo.